[January 20, 2017] |
|
Colorado BioScience Association Welcomes Nationally Recognized Thought Leaders to Address State's Medical Device Industry
Colorado
BioScience Association (CBSA) highlights how changes in federal
policy and major shifts in healthcare will impact the state's thriving
medical device industry as part of the annual CBSA Medical Device
Symposium. Medical device sector policy discussions will cover the
opportunities presented by proposed regulatory relief, corporate tax
reform and the possible full repeal of the medical device excise tax
under the new administration.
Additionally, speakers and panelists discussing national healthcare
trends, IP portfolio protections and the importance of partnering make
up the agenda for the symposium, scheduled for Tuesday, January 24th
at the Omni Interlocken Resort in Broomfield.
Highlights of the CBSA Medical Device Symposium, sponsored by Snell
& Wilmer Law Offices, include:
-
Federal policy preview by Clayton
Hall, Vice President of Government Affairs for the Medical Device
Manufacturing Association
-
New national data and insights on the medtech sector from John
Babitt, EY Medical Technology Leader for the Americas
-
Panel discussion: Protecting Your IP Portfolio
-
Panel discussion: Leveraging Partnerships for Success
April Giles, President & CEO of CBSA, says:
"CBSA is proud to bring nationally recognized industry leaders to engage
with Colorado companies and provide insights to support our sector's
success in a rapidly changing healthcare landscape."
Supporting sponsors of the symposium include: Snell
& Wilmer, EY,
and Fitzsimons
Redevelopment Authority.
The conference will be held from 1-5:30 p.m. at the Omni Interlocken
Resort, 500 Interlocken Boulevard, in Broomfield. Registration
is $50 for CBSA members and $100 for non-members.
Connect with CBSA: Twitter (News - Alert) @COBioscience, Facebook
and LinkedIn
About the Colorado BioScience Association
Colorado BioScience Association champions life science. We serve as the
hub of Colorado's thriving bioscience sector by connecting innovators to
funding, infrastructure, research and talent. From promising young
companies to established corporations and institutions, we provide
opportunities for networking, education and professional development. We
grow the bioscience workforce and lead business expansion policies to
advance the industry in our state. CBSA represents more than 350 member
organizations, including biotechnology, pharmaceutical, medical device,
diagnostic, ag bio and mobile digital health companies, research and
academic institutions and service providers. Learn more about us at http://www.cobioscience.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170120005665/en/
[ Back To Mobile World Congress's Homepage ]
|